Reasons for enhanced activity of doxorubicin on co-delivery with octa(3-aminopropyl)silsesquioxane.
Kinga PioreckaJan KurjataIrena I Bak-SypienMarek CyprykUrszula SteinkeWlodzimierz A StanczykPublished in: RSC advances (2020)
This paper presents results of spectroscopic (NMR, FTIR, fluorescence), Q-TOF mass spectrometry and Z -potential analyses of interactions between octa(3-aminopropyl)silsesquioxane hydrochloride (POSS-NH 2 ·HCl) and anticancer drug - doxorubicin hydrochloride. These studies aimed at explanation of the enhanced activity of doxorubicin on co-delivery with POSS-NH 2 . The results point to the formation of active complexes via ionic interactions between the ammonium chloride groups of silsesquioxane and the drug, and not, as suggested earlier, via NH⋯N hydrogen bonding. It has also been shown that the main driving force for the formation of the complexes can be strengthened by π-π stacking and hydrogen bonds. The experimental results are supported by quantum mechanical calculations. This work has proven that co-delivery with POSS offers a potentially advantageous and simple approach for improved efficacy in chemotherapy, avoiding often complicated synthesis of conjugates, involving covalent bonding between drug, nanocarrier and targeting agents.
Keyphrases
- cancer therapy
- drug delivery
- mass spectrometry
- room temperature
- molecular dynamics
- high resolution
- single molecule
- ionic liquid
- adverse drug
- liquid chromatography
- molecular docking
- magnetic resonance
- drug induced
- ms ms
- perovskite solar cells
- molecular dynamics simulations
- density functional theory
- solid state
- gas chromatography
- squamous cell carcinoma
- energy transfer
- locally advanced
- human health
- monte carlo
- case control